Oral Agents for Treatment of Patients with Advanced Pancreatic Neuroendocrine Tumors: Could Pharmaeconomic, Cost-Effectiveness Data Play a Significant Role?

Author(s): Maria Elisa Barna, Ilaria Uomo, Maurizio Pastorello

Abstract | Full-Text | PDF

Share this